Despite its toxicity, a great deal of attention has been paid to the anorexic effect of capsaicin in the treatment of obesity-related neurotransmitters/neuromodulators . To determine if capsaicin has any effects on the orexigenic or anorexigenic peptides , the neu ropeptide Y (NPY) and cholecystokinin (CCK)-imunoreactivities were demonstrated in the rat hypothalamus by immunohistochemistry after capsaicin administration . There was a significantly lower concentration of NPY immunopositive cells in the arcuate and paraventricular nuclei of the capsaicin treated rats. In contrast, the CCK expressions level was higher in the paraventricular nucleus of the capsaicin treated rats than in the control rats. These results suggest that capsaicin influence neuropeptides such as orexigenic NPY and anorexigenic CCK related to control food intake.
Capsaicin, the major pungent agent present in hot red pepper, has long been used as an important ingredi ent in most spicy foods (1) . Since its initial identification in 1919, numerous pharmacological effects have been reported and intensively studied (1) (2) (3) . It is known that adding capsaicin to high-fat meals decreases the appe tite while also lowering the perineal adipose tissue weight in rats in a dose-dependant manner (3, 4) . Moreover, in the aspect of the appetite and energy intake, capsaicin decreases the subsequent protein and fat intakes as well as the appetite in humans (3) .
Many studies have been performed on the specific mediators, receptors and neuronal circuits that regu late the food intake and body weight related to obesity. Peptidergic feeding-regulating neurons have been found in both the hypothalamus and the brainstem, where they act as input stations for hormonal and gas trointestinal information (5) .
The hypothalamus has been reported to regulate many aspects of energy homeostasis, adjusting both food intake and energy expenditure in response to vari ous nutritional and other signals (6) . In many hypotha lamic nuclei, both the arcuate nucleus (ARC) and the paraventricular nucleus (PVN) are related with the important centers that regulate food intake (5, 7). The ARC, which is located in the mediobasal hypothalamus, has been implicated with the control of the feeding behavior by a number of different approaches. Brob erger and Hokfelt (5) reported that the ARC could func tion as a metabolic sensor, mediating the endocrine information that controls the supply and demand of energy in the body. The PVN regulates several responses during the periods of altering energy availability because it possesses the anatomically proper projections to the autonomic and endocrine control sites involved in maintaining homeostasis (8) . These nuclei exert their functions through various neurotransmitters such as neuropeptide Y (NPY), cholecystokinin (CCK) , agouti related protein (AgRP) and orexin, by affecting the feed ing and energy expenditures (5-7, 9, 10) .
Among these neurotransmitters, NPY, a peptide con sisting of 36-amino acid residues and a member of the pancreatic polypeptide family, is distributed abundantly throughout the mammalian brain (11) . NPY is synthe sized throughout the brain, but particularly abundant in the hypothalamus. In the brain, the actions of NPY for energy homeostasis are exerted mostly within the hypothalamus (12) . Increases in both biosynthesis and the release of NPY along the distinct neuronal circuits constitute a specific hypothalamic response to the stim ulation of food intake (13) . Therefore, NPY is believed to be a key neurotransmitter in the regulation of food intake and energy homeostasis (14, 15) .
CCK, a 33-amino acid polypeptide, was originally iso lated from the duodenum and is widely distributed in the CNS of many species (9, 16) . CCK is present in sig nificant amounts in the brain, and acts as either a neu 
DISCUSSION
Many studies have reported that the food-intake con ditions such as feeding and fasting influence the NPY and CCK content in the CNS. Also, NPY and CCK con centrations in specific brain areas are altered by feeding and fasting, respectively (13, 17) . Moreover, NPY and CCK are known to function as signal mediators, regu lating food intake and the body weight balance in the hypothalamus (14) (15) (16) .
NPY is believed to be a powerful inducer of feeding and obesity, stimulating feeding on its own and releas ing other orexigenic agents, such as AgRP and orexin (6) . Exogenous NPY, particularly when injected intrace rebrally, stimulates a strong feeding behavior in experi mental animals, considerably increasing food intake (18) . In the hypothalamus, NPY is synthesized prima rily in the ARC, where the NPY neurons project their axons to several other hypothalamic nuclei including the PVN (6, 12) .
In this study, the NPY-like immunoreactivity (NPY-LI) was altered in both ARC and PVN after capsaicin injections. NPY-LI was observed in many neurons of the ARC in both the colchicine and non-colchicine treated animals. However, the immunointensity appeared weak in the non-colchicine treated animals. The number of NPY-immunoreactive neurons of the ARC decreased markedly after capsaicin treatment, These results sug gest that capsaicin affect NPY expression in the ARC neurons. In contrast to the ARC, NPY-LI of the PVN was observed only in the fibers of the non-colchicine treated rats.
The physiological role of the ARC neurons is to sense and respond to negative energy balance states, and for the NPY neurons of the ARC, by releasing NPY into the PVN, to protect against starvation and contribute to hyperphagia and obesity (6) . Accordingly, the diminish ment of NPY expression by capsaicin administration, as confirmed in this study, suggests that capsaicin may relate to food intake by affecting the NPY neurons in the ARC.
CCK is a satiety signal (19, 20) , and endogenous cen tral CCK is believed to act as a central satiety factor (16) . It has been reported that exogenously adminis tered CCK inhibits food intake in rats, and that the behavioral changes caused by CCK are consistent with the production of satiety (18) . Moreover, alteration of the feeding status might change not only the brain CCK levels, but also the CCK receptor concentrations in spe cific regions of the mouse brain (20) . Moran (10) sug gested that CCK affects food intake by itself and/or by interactions with other hormones or neuropeptides, and that the regulation of food intake is dependant on alterations of the CCK sensitivity. Ingram et al. (21) reported that CCK and CCK mRNA exist in some hypo thalamic nuclei including the PVN. It is also known that the gastric vagal afferents, which are related to the satiety effect of CCK, terminate the cell bodies in the nucleus tractus solitarius, the axons that project to the PVN (12) .
In this study, CCK-like immunoreactivity (CCK-LI) was observed only in the PVN of the colchicine treated rats, but not in the ARC in any of the experimental groups. The number of CCK immunoreactive cell bodies and fibers in the PVN was higher in the capsaicin treated rats (approximately 2-fold) than in the control group. The enhanced CCK of the PVN suggests that cap saicin increases in the anorexigenic effect of CCK. Bald win et al. (16) reported that the PVN is an important target site for mediating the hypophagic actions of CCK. They suggested that PVN lesions abolish the inhibition of the food intake by CCK administration. In this study, it was not confirmed whether or not the CCK of PVN was synthesized by PVN itself. However, it could be pos tulated that the enhanced CCK-LI of the PVN after cap saicin treatment promote the anorexigenic function of CCK.
The results of this study indicate that the administra tion of capsaicin decreases the orexigenic NPY expres sion, but increases the anorexigenic CCK expression in the neurons of the hypothalamic nuclei. The effect of capsaicin described in this study supports that reported in previous studies, which showed that capsaicin is closely related to reduced food intake and adipose tissue weight (3) .
In summary, these results give anatomical support for the hypothesis that capsaicin plays an inhibitory role in food intake by changing the NPY and CCK expression pattern in the hypothalamic nuclei.
